










































































































































































































































































































































































































































































































































































































































































































































































































































































































Background Measures 1 2 8 9 10 11 12 16 17 25 Case ID  
  Numbers 
Patient Type FTD FTD MND MND MND MND MND FTD FTD AD Controls(n=9) 
  mean score 




Brixton Standardized Score  1* 6 6 2* 2* 2* 6 1* 7.25 
Written Verbal Fluency Z score  1.92 1.26 0.79 ‐0.43 10.35* 0.0022 
Spoken Verbal Fluency Z score  12.61* 6.57* 2.4* 1.58 2.83* 4.03* 3.9* 1.85 11.1* 0.0033 
   
Verbal Intelligence/Language Abilities   
WASI Vocab T score 53* 59 61 59 69 62.44 
WASI Similarities T score 56 49* 54 56 64 60 
WASI Verbal IQ score 107* 106* 115 111 129 118.11 








GNT  12 24 28 27 26 16 28 27 24.67 
   
Visuospatial Abilities  
VOSP Number Location 1* 10 10 8 10 10 5* 9.11 












































































































































































Patient Type  FTD  FTD MND MND MND MND FTD  FTD  AD
Self Rating Total T Scores    86* 47 48 40 66*   45   
Family Rating Total T scores  61  48 46 49 47 42 58    50
FrSBe After Total T scores  1  2  8  9  10  12  16  17  25 
CaseI
D 
Patient Type  FTD  FTD MND MND MND MND FTD  FTD  AD 
Self Rating Total T Scores    99* 54 60 38 74* 55   





























































































IRI Total   1  2  8 9 10 12 16  17  25 Case ID
Scores           
Patinet Type  FTD  FTD  MND  MND  MND  MND  FTD  FTD  AD 
Controls(n=9) 
mean score 
Self Rated    60  80 21* 74 77    62.78
Carer Rated 
Premorbid  61  48  69  64  57    49    40  62.78 
Carer Rated 








































































OIGT 1 2 8 9 10 11 12 16 17 Case ID 
    
Patient Type FTD FTD MND MND MND MND MND FTD FTD Control  (n=8)
Total Advantageous            
Deck Selections (100 
trials) 49 53 69 52 58 44 44 50 53 68.75 
           
Trial Blocks (20 trials)           
Block 1 11 9 11 9 12 8 9 9 16 12.125 
Block 2 8 11 12 10 17 13 7 10 5 14 
Block 3 8 10 15 11 12 11 11 9 9 14.5 
Block 4 12 9 16 11 7 7 6 11 9 14.125 





























































SIGT        
  1  2  8 9 10 12 17  25  Case ID





(100trials)  21*  57*  69  51*  44*  84  53*  60*  85.71 
       
Trial Blocks (20 trials)       
Block 1  7*  12*  18  10*  14  17 13  8*  16.2857 
Block 2  0*  12  19 13 9* 16 13  13  17.1429 
Block 3  0*  12*  20 12* 6* 18 18  16  18.5714 
Block 4  9  11  7 7 6 18 9  12  12.5714 








































































Reversal Learning Task  1  8 9 10 12 17 25  Case ID




Amount of Money  ‐6924  ‐2376 ‐12491 ‐3933 ‐1190 ‐6155 ‐7980  ‐2247.5
Amount of Switches  2  3 4 3 5 2 3  4.5
Hits until Switch 1  12  9 9 9 10 15 9  16.38
Hits after Switch 1  44  49 56 52 55 43 40  46
Percentage Accuracy  53.7  55.7 61.5 57.1 62.5 58.1 44.4  60.26












































































































































































































































































































































































































































































































CONSENT FORM - Confidential 
 
 
Title of project: Brain regions associated with changes in social behaviour 
 
Name of Researcher:  Dr Sarah MacPherson 
 
Please initial box 
 
1. I confirm that I have read and understand the information sheet dated 06.11.06 (version 2B) 
for the above study and have had the opportunity to ask questions. 
  
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my or my partner/relative/friend’s medical care or legal 
rights being affected. 
 
3. I agree to take part in the above study. 
 
 
____________________________   _________  ______________________ 
Name of Carer                    Date   Signature 
 
_____________________________  _________  ______________________ 
Name of Person taking consent        Date   Signature 
(if different from researcher) 
 
_____________________________  _________  ______________________ 
Researcher                 Date   Signature 











































































































































Edinburgh, 19th of May, 2011 
Dear 
 
Your details were given to me by the Scottish Dementia Clinical Research Network and I am 
writing to ask whether you would be willing to participate in a research project. The project is 
run by myself and colleagues at the University of Edinburgh and investigates aspects of 
language, thinking and behaviour in people with different neurological conditions.  
 
Participation involves an interview including some problem solving tasks, and several 
questions about how you are feeling. In addition, someone who knows you very well like 
your partner, a relative or a friend, would be asked to answer some questions during a brief 
interview. The interview can be undertaken at your home, or if you prefer at the University of 
Edinburgh. I am enclosing copies of the information sheets, which provide more detailed 
information.  
 
Please read the information sheets thoroughly prior to deciding whether you would like to 
take part in this study. It is entirely your choice whether or not to take part and you do not 
have to give any reason if you choose not to participate. Please also note that such a 





If you are interested in helping with this work, I would be grateful if you could contact either 
Denise Rogers, Lindsay Oliver or myself, by phone or by e-mail, or by posting the attached 
reply slip (stamp included). Contact details are provided on the information sheets. 
 
If you would like to obtain further information or talk to someone about the study before 
making your decision, please do not hesitate to contact me on 0131 650 3339. Thank you for 







































Edinburgh, 1st of June, 2011 
Dear 
 
I am running a research study on aspects of language, thinking and behaviour in people with 
different neurological conditions and I wondered whether you would be willing to help in this 
research project.  
 
Participation involves an interview including some problem solving tasks, very similar to 
those you undertook with me in our session together, and several questions about how you 
are feeling. In addition, someone who knows you very well like your partner, a relative or a 
friend, would be asked to answer some questions during a brief interview. The interview can 
be undertaken at your home, or if you prefer at the University of Edinburgh. I am enclosing 
copies of the information sheets, which provide more detailed information.  
 
Please read the information sheets thoroughly prior to deciding whether you would like to 
take part in this study. It is entirely your choice whether or not to take part and you do not 
have to give any reason if you choose not to participate. Please also note that such a 





If you are interested in helping with this work, I would be grateful if you could contact Denise 
Rogers, Lindsay Oliver or myself, either by phone, by e-mail or by posting the attached reply 
slip (stamp included). Contact details are provided on the information sheets. 
 
If you would like to obtain further information or talk to someone about the study before 
making your decision, please do not hesitate to contact me on 0131 650 3339. Thank you for 













































Study title: “Language, Thinking and Behaviour in Different Neurological Conditions” 
 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part.  
 





Clinical experience and research studies have shown that people with some neurological 
conditions have difficulties with language, thinking or behaviour. Using a battery of 
neuropsychological tests and questionnaires we aim to investigate what type of changes 
people with different neurological conditions experience in their language, thinking and 
behaviour. These results will be compared to a group of participants who do not have 
neurological problems.  
 
Why have I been chosen? 
 
We will be seeing a total of 20 people with various neurological conditions. We will also be 
seeing a total of 20 healthy control participants. 
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time and without giving a 
reason. A decision to withdraw at any time, or a decision not to take part, will not 




What will happen to me if I take part? 
 
The study will consist of an interview during which you will undertake a series of 
simple tasks, similar to word games and puzzles, some of which will take place on a 
computer. We will also ask you to complete a few questionnaires. The interview will 
be divided into two separate visits lasting approximately 2 hours each. The 
interviews can take place at your home at a time of your convenience, or at the 
Department of Psychology, University of Edinburgh, 7 George Square, if you prefer. 
You will be reimbursed for your travelling and parking expenses if you do decide to 
come to the University of Edinburgh.  
 
During the interview we may sometimes ask to audio-record your voice whilst you 
are performing some of the tasks. We ensure that there will be nothing on the tape 
that could identify you in person and that these tapes will be destroyed once the data 
has been obtained. 
 
As part of the study, we would separately like to ask a carer or relative who knows 
you well some questions. We are interviewing carers to try and get as many 
perspectives as possible on changes in behaviour that may, or may not occur in 
people with neurological problems. This will consist of them having a brief interview 
that will enquire about any changes that may have occurred since the onset of your 




This will take up to half an hour. Any responses given to us by your carer will remain 
confidential and we will not reveal them to you. You will also be asked to fill out a 
version of these questionnaires related to any changes you may have noticed 
yourself. We will not tell your carer how you responded to any of the questionnaires. 
 
What do I have to do? 
 
You will not have to come off medication or undergo any invasive procedure 
whatsoever. Most tests are in the forms of interviews, questionnaires or puzzle-like 
tests. If you are unable to write we will assist you in filling out the questionnaires. If 
you are unable to speak we may skip certain tests that rely on spoken answers.  
 
If you agree to join the study, your General Practitioner will be sent a letter and 
informed that you have agreed to take part in this study. We will ask you for 
permission to inform your General Practitioner. 
 
What are the possible disadvantages and risks of taking part? 
 
We do not anticipate any health risks from taking part in this study. Due to the 
length of the interview you may find testing to be tiring, but you will be given 
plenty of opportunity to take breaks. If you feel distressed at all by the 
interview please do not hesitate to contact Dr Sharon Abrahams 0131 650 3339 
(project leader).  
 
 
What are the possible benefits of taking part? 
 
There will be no direct benefit to you or your carer by taking part, and your individual 
results will not be revealed to you. However, we will make any future publications of 
the findings available to you. It is hoped that this research will improve our 
knowledge relating to various neurological conditions and may influence care 
practices in the future. 
 
What if something goes wrong? 
 
Whilst we do not anticipate any adverse effects from taking part in this study, if you 
are harmed by taking part in this research project, there are no special compensation 
arrangements. If you are harmed due to someone’s negligence, then you may have 
grounds for a legal action but you may have to pay for it. Regardless of this, if you 
wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated during the course of this study, the normal National Health 
Service complaints mechanisms should be available to you. 
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the research will be kept strictly 
confidential. Only people from the research team and the clinical team at your hospital may 
have access to your medical records and notes. Any information about you which leaves the 




You will be allocated an anonymous ID code during testing which will be used in place of 
your name in our testing materials, computers or on any future publications. 
 
What will happen to the results of the research study? 
 
The results of the research will be published in appropriate peer-reviewed scientific journals 
for distribution to other healthcare professionals. Talks and presentations may be made at 
meetings and conferences. In all cases, your name and personal details will not be 
identified. 
 
Who is organising the research? 
 
The study is being organised by Dr. Sharon Abrahams and Dr. Sarah MacPherson from the 
University of Edinburgh, in collaboration with the Western General Hospital (Edinburgh). 
 
Who has reviewed the study? 
 





Contact for Further Information 
 
If you wish to ask anything further, please contact us, the researchers, Denise Rogers or 
Lindsay Oliver: 
 
Department of Psychology, PPLS  
7 George Square 







0131 651 5019  
  
If your call is unanswered, please leave a message on the answering machine and we will 
get back to you as soon as possible.  
 
Thank you for reading this information sheet. You will be given a copy to keep. If you have 
understood the contents of this sheet and wish to take part, please complete the consent 












































Information Sheet for Carers 
 
Study title: “Language, Thinking and Behaviour in Different Neurological Conditions”  
 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part.  
 
What is the purpose of the study? 
 
Clinical experience and research studies have shown that people with some neurological 
conditions have difficulties with language, thinking or behaviour. Using a battery of 
neuropsychological tests and questionnaires we aim to investigate what type of changes 
people with different neurological conditions experience in their language, thinking and 
behaviour. These results will be compared to a group of participants who do not have 





Why have I been chosen? 
 
Your partner, relative, or friend who has a neurological condition has volunteered to take part 
in this study and we would like to ask you some questions about how their behaviour may 
have changed since the onset of symptoms. We will be seeing a total of 20 people with 
various neurological conditions. We will also be seeing a total of 20 healthy control 




Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time and without giving a 
reason. A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care which you or the person with neurological problems 
receives, now or in the future. 
 
What will happen to me if I take part? 
 
The study will consist of one interview during which you will be asked some 
questions relating to any changes you may have noticed in the behaviour of your 
partner/relative/friend with neurological problems. This should take approximately 30 
minutes. Any responses given to us by you will remain confidential.  
 
What do I have to do? 
 
You will not have to take medication or undergo any invasive procedure whatsoever. 
Tests are in the forms of an interview and questionnaires. 
 
What are the possible disadvantages and risks of taking part? 
 
We do not anticipate any health risks from taking part in this study. If you feel 
distressed at any time during the interview it is important that you let the interviewer 
know straight away. If you feel distressed after the interview, please contact Dr. 
Sharon Abrahams 0131 650 3339 (project leader).  
 
What are the possible benefits of taking part? 
 
There will be no direct benefit to you or your partner/relative/friend by taking part, 
and your individual results will not be revealed to you. However, we will make any 




improve our knowledge relating to various neurological conditions and may influence 
care practices in the future. 
 
What if something goes wrong? 
 
Whilst we do not anticipate any adverse effects from taking part in this study, if you 
are harmed by taking part in this research project, there are no special compensation 
arrangements. If you are harmed due to someone’s negligence, then you may have 
grounds for a legal action but you may have to pay for it. Regardless of this, if you 
wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated during the course of this study, the normal National Health 
Service complaints mechanisms should be available to you. 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the research will be kept strictly 
confidential, and we will not tell your partner/relative/friend about your answers. Only people 
from the research team will see your information. You will be allocated an anonymous ID 
code during testing which will be used in place of your name in our testing materials or on 
any future publications. 
 
What will happen to the results of the research study? 
 
The results of the research will be published in appropriate peer-reviewed scientific journals 
for distribution to other healthcare professionals. Talks and presentations may be made at 
meetings and conferences. In all cases, your name and personal details will not be 
identified. 
 
Who is organising the research? 
 
The study is being organised by Dr. Sharon Abrahams, Dr. Sarah MacPherson, Denise 
Rogers and Lindsay Oliver from the University of Edinburgh, in collaboration with the 
Western General Hospital (Edinburgh). 
 
Who has reviewed the study? 
 
This study has been granted ethics approval by the Lothian Research Ethics Committee.  
 





If you wish to ask anything further, please contact us, the researchers, Denise Rogers or 
Lindsay Oliver:   
   
Department of Psychology, PPLS 
7 George Square 




0131 651 5019 
 
If your call is unanswered, please leave a message on the answering machine and we will 
get back to you as soon as possible.  
Thank you for reading this information sheet. You will be given a copy to keep. If you have 
understood the contents of this sheet and wish to take part, please complete the consent 






























Dr <Name of GP> 





DD Month YYYY 
 
Dear Dr <Name of GP> 
 
 
RE:  <Title + Patient first- and surname>  (DOB dd/mm/yy) 
 <Street>  
 <City> 
 <Postal Code> 
 




research study entitled <Enter study title depending on patient group> with Edinburgh 
University. This is a non-invasive study involving interviews in which participants undertake a 
number of neuropsychological tests (language and problem solving) and questionnaires 
addressing issues of behaviour and emotion changes. We are contacting you to inform you 
of <Title + Patient surname’s> participation in accordance with ethical guidelines. I enclose 
an information sheet.  
 








Dr. Sharon Abrahams 



















































Appendix I: WAIS Exclusion Criteria 
EXCLUSION CRITERIA 
 
PLEASE LET THE EXPERIMENTER KNOW IF ANY OF THE FOLLOWING APPLY.  YOU DO NOT HAVE TO 
STATE WHICH ONE. 
 Colour‐blindness 
 
 Uncorrected hearing loss 
 
 Uncorrected visual impairment 
 
 Current treatment for alcohol or drug dependence 
 
 Seeing a doctor or other professional for memory problems or problems with thinking 
 
 A condition that would prevent arm movement and/or the use of both hands 
 
 Any period of unconsciousness for 5 minutes or more 
 
 Head injury resulting in hospitalisation for more than 24 hours 
 
 Currently taking antidepressant, anti‐anxiety, or anti‐psychotic medication 
 
 Medical or psychiatric condition that could potentially affect cognitive functioning, such as: 
 
 Stroke 
 ECT (electric shock treatment) 
 Epilepsy 
 Brain surgery 
 Encephalitis 
 Meningitis 
 Multiple sclerosis 
 Parkinson’s disease 
                                                                                                                                                                                                                   
74 
 
 Huntington’s chorea 
 Alzheimer’s dementia 
 Schizophrenia 
 Bipolar disorder 
 
 
 
 
 
 
 
 
 
 
 
 
